1 Apr 2021 16:23
1 April 2021
Kainos Group plc
("Kainos" or the "Company")Β
Total Voting Rights
Β
Pursuant to DTR 5.6.1 the Company announces that as at 1 April 2021, the total number of ordinary shares in issue now stands at 122,785,147 each with voting rights. There are no shares held in treasury.
Β
The above figure (122,785,147) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Β
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Β
Classification: 2.5 - Total number of voting rights and capital
Β
Ends
Β
For further information, please contact:
Β
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Β
Investec Bank plc +44Β 20 7597 5970
Patrick Robb / Ben Griffiths
Β
Canaccord Genuity +44 20 7523 4606
Simon Bridges/ Emma Gabriel
Β
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Dwight Burden / Kwaku Aning
Β
About Kainos
KainosΒ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Β
Β
The Group's Digital Services include full lifecycle development and support ofΒ customisedΒ Digital Services for government and commercial customers.Β KainosΒ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Β
Β
The Group's Digital Platforms compriseΒ specialisedΒ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theΒ digitisationΒ of patient notes in the Acute sector of the NHS.
Β
Kainos has over 1,700 people across 15 offices in Europe and North America.
KainosΒ is listed on the London Stock Exchange (LSE: KNOS). For further information, please visitΒ www.kainos.com.
Β
Β
Β
Follow the stocks